Log in

WST WEST PHARMACEUTICAL SERVICES INC NYSE · United States

WEST PHARMACEUTICAL SERVICES INC (WST) news

Latest WEST PHARMACEUTICAL SERVICES INC news

We have not published a story on WEST PHARMACEUTICAL SERVICES INC yet. When there is news, it will appear here.

WEST PHARMACEUTICAL SERVICES INC annual financials

LineFY2025FY2024
Research and development$74.3 million$69.1 million
Net income (loss)$493.7 million$492.7 million
Cash from operations$754.8 million$653.4 million
Cash and equivalents$791.3 million$484.6 million

Latest balance sheet, Sep 30, 2026 (10-Q): cash and equivalents $464.1 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about WEST PHARMACEUTICAL SERVICES INC

What is the ticker symbol of WEST PHARMACEUTICAL SERVICES INC?

WEST PHARMACEUTICAL SERVICES INC trades under the ticker WST on NYSE.

Where is WEST PHARMACEUTICAL SERVICES INC listed?

WEST PHARMACEUTICAL SERVICES INC is listed on NYSE.

Which country or territory is WEST PHARMACEUTICAL SERVICES INC listed under?

Our directory records WEST PHARMACEUTICAL SERVICES INC under United States.

Does aibio.space cover WEST PHARMACEUTICAL SERVICES INC?

aibio.space lists WEST PHARMACEUTICAL SERVICES INC among 2,820 public biotech companies and publishes its news here as stories appear.

Is WEST PHARMACEUTICAL SERVICES INC profitable?

WEST PHARMACEUTICAL SERVICES INC reported net income of $493.7 million for the fiscal year ended Dec 31, 2025, and generated $754.8 million of cash from operations, per its annual report to the SEC.

How much does WEST PHARMACEUTICAL SERVICES INC spend on research and development?

$74.3 million in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does WEST PHARMACEUTICAL SERVICES INC have?

$464.1 million in cash at Sep 30, 2026, per its 10-Q.

What is the latest WEST PHARMACEUTICAL SERVICES INC (WST) stock news?

Our latest story on WEST PHARMACEUTICAL SERVICES INC, dated Oct 26, 2026: "West Pharmaceutical enters $750 million revolver and $200 million term loan". Bank of America, N.A. is administrative agent under the new unsecured credit agreement. The company repaid $130.0 million under its 2019 credit agreement. Source.

Does WEST PHARMACEUTICAL SERVICES INC have debt, a term loan or convertible notes?

Our latest debt story, dated Oct 26, 2026: "West Pharmaceutical enters $750 million revolver and $200 million term loan". Bank of America, N.A. is administrative agent under the new unsecured credit agreement. The company repaid $130.0 million under its 2019 credit agreement. Source.

How can I follow WEST PHARMACEUTICAL SERVICES INC (WST) news?

Press Follow on this page to add WEST PHARMACEUTICAL SERVICES INC to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming WEST PHARMACEUTICAL SERVICES INC so far, in Debt Financing.

Investor discussion: WEST PHARMACEUTICAL SERVICES INC

Members talk about WEST PHARMACEUTICAL SERVICES INC (WST). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NYSE:WST on TradingView.

Listing details

WEST PHARMACEUTICAL SERVICES INC is a public biotech or pharmaceutical company listed on NYSE under the ticker WST, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
WEST PHARMACEUTICAL SERVICES INC
Ticker
WST
Listing
NYSE
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.